The U.S. Department of Justice (DOJ) confirmed the establishment of the Antitrust Division’s Task Force on Health Care Monopolies and Collusion (HCMC). There is significant interest among legal professionals on what impact this initiative could have on the healthcare industry.
The HCMC is a diverse group comprised of civil and criminal prosecutors, economists, healthcare experts, technologists, data scientists, investigators, and policy advisors. The task force, led by former antitrust prosecutor Katrina Rouse, will evaluate consolidation by healthcare payers and providers, serial acquisitions, the quality of healthcare services, and medical billing.
The formation of this task force coincides with a period of increased healthcare spending. As per 2022 records, national health spending escalated to $4.5 trillion. Large corporations, such as CVS, Amazon, and UnitedHealth Group, have been procuring physician practices, leading the DOJ to launch an antitrust investigation into UnitedHealth Group.
Seth Joseph from Summit Health Strategies comments on the need for a specialized task force due to the intricacies of the healthcare industry. Joseph stresses the need for a task force that fully understands the healthcare industry to ensure appropriate competition to serve patients. However, he also maintains it’s premature to speculate on the task force’s impact on healthcare monopolies and consolidation.
Tyler Giesting, director of West Monroe’s healthcare M&A group, observes that the task force has deliberately adopted a broad approach, implying an interest in addressing various forms of anti-competitive behavior, not solely focussing on payer and provider vertical integration.
Hal Andrews, president and CEO of Trilliant Health, contends that the HCMC should not solely focus on the prices consumers, employers, and CMS pay for healthcare. Rather, they should develop an extensive framework to address the tension between the need for consolidation to eliminate wasteful duplicate services and the desire to circumvent potential price increases resulting from such consolidation. According to Andrews, despite the belief that monopoly markets have higher prices, the CMS’s Transparency in Coverage initiative demonstrates that the three most competitive markets – New York, Los Angeles, and Chicago – actually have higher prices than monopoly markets.
The DOJ has insisted that targeting healthcare monopolies is necessary. Assistant Attorney General Jonathan Kanter expressed concern over concentrated power in healthcare, stating the effort to identify and eradicate monopolies and collusive practices would increase healthcare quality and decrease costs.
This news is extracted from the original article which can be found here.